The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis

BACKGROUND: Since the outbreak of Novel Coronavirus Pneumonia (NCP), it has swept the world with rapid development. Up to now, there is no effective drug to treat it. Lianhua Qingwen has been used in the treatment of COVID-19 in China, but there is no systematic review about it. This study will syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiongshuai, Cao, Fang, Ji, Guangcheng, Xu, Xiaohong, Sun, Yihan, Li, Jiannan, Qi, Xun, Sun, Shaoqian, Wang, Yufeng, Song, Bailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386949/
https://www.ncbi.nlm.nih.gov/pubmed/32791675
http://dx.doi.org/10.1097/MD.0000000000020979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386949/
https://www.ncbi.nlm.nih.gov/pubmed/32791675
http://dx.doi.org/10.1097/MD.0000000000020979

Ejemplares similares